You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Split-course Chemoradiotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)

Terminated
  • Non-small Cell Lung Cancer
  • chest radiation
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 25, 2022

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Split-course hypo-CCRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Aug 26, 2023

NSCLC Trial in Guangzhou (Concurrent chemo, split-course radiotherapy, thymosin alpha 1)

Completed
  • Non-small Cell Lung Cancer
  • Concurrent chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Dec 30, 2021

NSCLC Trial in Guangzhou (split-course radiotherapy, concurrent chemo)

Unknown status
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • concurrent chemotherapy
  • Guangzhou, Guangdong, China
    Hui Liu
Jan 15, 2021

NSCLC Trial in Guangzhou (split-course radiotherapy, Concurrent chemo)

Completed
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • Concurrent chemotherapy
  • Guangzhou, Guangdong, China
    Hui Liu
Apr 10, 2020

Locally Advanced Lung Carcinoma Trial in Guangzhou (Concurrent chemo and single radiation dose climbing)

Recruiting
  • Locally Advanced Lung Carcinoma
  • Concurrent chemotherapy and single radiation dose climbing
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 11, 2021

NSCLC Trial in Guangzhou (split-course radiotherapy, concurrent chemo)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • concurrent chemotherapy
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition Trial in Hefei (Whole-course Immunonutrition Combined

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs
  • Hefei, China
    Anhui provincial hospital
Apr 16, 2023

Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)

Not yet recruiting
  • Rectal Cancer
  • split-course hypofraction radiotherapy
  • +3 more
  • Fuzhou, Fujian, China
    Pan Chi
Jul 23, 2023

Esophageal Tumors, Adverse Drug Event Trial in Nanjing (dietary supplement, drug, radiation)

Recruiting
  • Esophageal Neoplasms
  • Adverse Drug Event
  • Nutritional Support Team
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Mar 23, 2023

Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,

Recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Hypofractionated Radiation Therapy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Rectal Cancer in a Tertiary Asian Institute

Completed
  • Rectal Cancer
  • Oncology
  • neoadjuvant long course chemoradiotherapy
  • (no location specified)
Oct 31, 2022

Chemotherapy and Tislelizumab With Split-course HFRT for Locally

Recruiting
  • Rectal Cancer
  • Radiation Oncology
  • split-course HFRT
  • +2 more
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Apr 26, 2022

Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course

Not yet recruiting
  • Locally Advanced Rectal Carcinoma
  • Short course radiotherapy with concurrent capecitabine(825mg/m2)
  • Long course radiotherapy with concurrent capecitabine(825mg/m2)
  • (no location specified)
Jun 24, 2023

Rectal Cancer Trial in Korea, Republic of (radiation, drug, procedure)

Recruiting
  • Rectal Cancer
  • short-course radiotherapy
  • +3 more
  • Daegu, Korea, Republic of
  • +8 more
Jan 8, 2023

Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1

Recruiting
  • Colorectal Neoplasms
  • long course radiotherapy + capecitabine + PD-1 monoclonal antibody
  • Beijing, Beijing, China
    Beijing Friendship Hospital
May 5, 2022

Colorectal Tumors Trial in Beijing (long course radiotherapy + capecitabine + PD-1 mAb treatment combinations)

Recruiting
  • Colorectal Neoplasms
  • long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Feb 7, 2022

Locally Advanced Rectal Cancer Trial (PD-1 inhibitor, Capecitabine, Long-course radiation therapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • PD-1 inhibitor
  • +2 more
  • (no location specified)
Aug 16, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 11, 2022

Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

Recruiting
  • Locally Advanced Rectal Carcinoma
  • +2 more
  • Gainesville, Florida
  • +1 more
Jan 4, 2023

Neoadjuvant Therapy in Rectal Cancer Trial in Poland, United Kingdom, United States (E7046, Long Course Chemoradiotherapy

Completed
  • Neoadjuvant Therapy in Rectal Cancer
  • Boston, Massachusetts
  • +4 more
Oct 1, 2021

Rectal Cancer Trial in Worldwide (M1 scheme, standard long course chemoradiotherapy)

Active, not recruiting
  • Rectal Cancer
  • M1 scheme
  • standard long course chemoradiotherapy
  • Saint Louis, Missouri
  • +55 more
Jan 11, 2023

NSCLC Trial in Guangzhou (split-course radiotherapy, concurrent chemo)

Unknown status
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • concurrent chemotherapy
  • Guangzhou, Guangdong, China
    Hui Liu
Apr 9, 2019

Rectal Cancer Trial in Beijing (combination product, radiation, drug, procedure)

Recruiting
  • Rectal Cancer
  • Concurrent Chemoradiotherapy Radiotherapy
  • +5 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jun 6, 2021